Rein Therapeutics, Inc. (RNTX)
NGM · Common · CUSIP 00887A105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RNTX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
00887A105
Market Cap
Micro Cap
IPO
6/29/2017 · $15.00/share
Previous Symbol
ALRN (changed 12/10/2024)
Previous Name
Aileron Therapeutics, Inc.
Business: Rein Therapeutics, Inc.. is a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications.

Company Contact

CEO
Brian Windsor
CFO
Tim Cunningham
Headquarters
12407 N. Mopac Expy., Suite 250, #390, Austin, TX 78758
Phone
737-802-1989
Fax
617-995-2410
Investor Relations
Argot Partners · 212-600-1902 · Rein@argotpartners.com
General Email
info@aileronrx.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »